GENE ONLINE|News &
Opinion
Blog

Cancer
R&D CCR8
Gilead Adds Jounce to its Long List of Oncology Partnerships
2020-09-03
In-Depth Anti-CD38
Spotlight: Infusion-Related Reactions Associated with Rapid Infusion of Daratumumab
2020-08-31
Trials & Approvals
Bristol-Myers-Squibb Anticipates FDA Approval for CC-486 as a Treatment for Acute Myeloid Leukemia
2020-08-30
Technology Cancer
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Trials & Approvals ESCC
Keytruda Receives Two New Approvals in Japan
2020-08-30
Funding Cancer Screening
Freenome Receives $270 Million Funding for Early Cancer Detection
2020-08-27
Funding Genetic test
UK Startup Biofidelity Ltd. Acquires $12 Million in Series A Financing
2020-08-23
Technology Cancer
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
In-Depth Oncology
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
The Influential Role of Gut Microbiome in Cancer Therapy
2020-08-06Partner
Anti-PD-1
BioNTech to Test mRNA-Based Cancer Vaccine with Regeneron’s anti-PD1 Drug in Melanoma Patients
2020-08-04
Deals
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
Funding
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
New Frontiers in Therapeutics
2020-07-25Partner
BIO Asia-Taiwan 2020: Nobel Laureate Prof. Tasuku Honjo Reflects on the Future of Cancer Immunotherapy
2020-07-22Partner
1 … 15 16 17 18 19 … 22
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top